We are live on ! Find out more
OKYO

OKYO Pharma
OKYO

1 hedge funds and large institutions have $14.4K invested in OKYO Pharma in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

379% more capital invested

Capital invested by funds: $3K → $14.4K (+$11.4K)

0% more funds holding

Funds holding: 1 → 1 (0)

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$13.9K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$14.4K +$13.9K +6,341 +536%

OKYO Hedge Fund Activity: Q4 2022 in Review

1 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in OKYO Pharma (OKYO) for Q4 2022, worth a combined $14.4K — up 379% from $3K a quarter earlier.

Fund positioning in OKYO was balanced in Q4 2022: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, adding an estimated $13.9K.

  • 1 institutional investor held OKYO Pharma (OKYO) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $14.4K of OKYO Pharma stock for Q4 2022, up 379% quarter-over-quarter.
  • 0 funds opened new OKYO Pharma positions in Q4 2022 and 0 closed out.
  • The largest OKYO Pharma buyer in Q4 2022 was UBS Group, an estimated $13.9K added.

Based on aggregated 13F filings for Q4 2022.